Loading interface...

Mypred 125 MG Injection

Manufactured bySamarth Life Sciences Pvt. Ltd.
Description

Mypred 125 MG Injection is a corticosteroid that is used to relieve swelling in various conditions like arthritis and allergic disorders. Do not stop the use of this medicine suddenly since this may cause severe side effects like confusion, headache, etc.

Side effects

Major & minor side effects for Mypred 125 MG Injection

  • Aggression or anger
  • Decreased urine output
  • Dizziness
  • Headache
  • Difficulty in breathing
  • Change in mood
  • Increased appetite

Uses of Mypred 125 MG Injection

What is it prescribed for?

  • Acute Gout
  • Nephrotic syndrome
  • Rheumatoid Arthritis
  • Asthma
  • Osteoarthritis
  • Bursitis
  • Lichen simplex chronicus
  • Lichen Planus
  • Keloids
  • Granuloma annulare
  • Allergic rhinitis
  • Tendonitis
  • Synovitis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 6 to 48 hours after intramuscular administration. The onset of action is rapid after intravenous administration.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to methylprednisolone, or any other inactive ingredients present in the formulation.

Fungal infections

This medicine is not recommended for use in patients suffering from systemic fungal infections due to the increased risk of worsening of the patient's condition.

Idiopathic thrombocytopenic purpura

Intramuscular injection of this medicine is not recommended for use in patients with a known history of Idiopathic thrombocytopenic purpura due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Infections

This medicine is not recommended for use in patients suffering from systemic infections since it may worsen the patient's condition. Patients who are at risk of developing infections should be monitored closely during treatment with this medicine for any signs of infections. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Vaccination

Administration of live or attenuated vaccines is not recommended in patients receiving immunosuppressive doses of this medicine due to the increased risk of serious adverse effects. Your doctor may advise you on an appropriate time gap between the administration of the vaccine and the medicine or suggest an alternative medicine or alternative means of vaccination based on your clinical condition.

Diabetes

This medicine should be used with caution in patients with a known history of diabetes mellitus due to the increased risk of altered blood glucose levels. Close monitoring of blood glucose levels is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Gastrointestinal diseases

This medicine should be used with caution in patients with gastrointestinal diseases due to the increased risk of gastrointestinal bleeding. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Kidney disease

This medicine should be administered with caution in patients with a known history of kidney disease since it may worsen the patient's condition. Close monitoring of kidney function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Liver disease

This medicine should be administered with caution in patients with a known history of liver disease due to the increased risk of severe adverse effects. Close monitoring of liver function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ethinyl Estradiol

Azole antifungal agents

Antihypertensives

Nonsteroidal anti-inflammatory drugs

Disease interactions

Gastro-intestinal bleeding

This medicine should be used with caution in patients with a known history of gastrointestinal diseases due to the increased risk of bleeding. This risk is especially higher when the medicine is taken for a long duration of time. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Diabetes

This medicine should be used with caution in patients with a known history of diabetes due to the increased risk of altered blood glucose levels. Regular monitoring of blood glucose levels, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
It works by binding to the receptors and inhibiting the release of certain chemical substances that cause inflammation.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Glucocorticoids

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2020 [cited 28 January 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011856s103s104lbl.pdf

DailyMed - METHYLPREDNISOLONE ACETATE injection, suspension [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 28 January 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=769cc1ae-bdf4-47e4-9a9f-c6327bd7dbf4

Methylprednisolone - DrugBank [Internet]. Drugbank.ca. 2020 [cited 28 January 2020]. Available from:

https://www.drugbank.ca/drugs/DB00959

Depo-Medrone 40mg/ml Suspension for Injection - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2020 [cited 28 January 2020]. Available from:

https://www.medicines.org.uk/emc/product/8957/smpc
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 25 Feb 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.